Skip to main content
Menu
Return to Home
Home
Home
Guidance for supplying methadone and buprenorphine doses to third party in context of COVID-19 pandemic
Guidance for supplying methadone and buprenorphine doses to third party in context of COVID-19 pandemic
Details
Date published
16 Oct 2021
Downloads
Guidance for supplying methadone and buprenorphine doses to third party in context of COVID-19 pandemic
pdf
281 KB
Reviewed 17 October 2021
Share this page
Twitter
, opens a new window
Facebook
, opens a new window
LinkedIn
, opens a new window
Was this page helpful?
Yes
No
Tell me your email for content rating
